Becton Dickinson (BDX)

Exchange: New York Stock Exchange
Currency: USD

Price: 0.00 ()



52 Week range 200d Moving Avg. Beta
0.00 – 0.00 0.00 0.00
Dividend Dividend Yield Ex-Dividend date
0.00 0.00% 0000-00-00
P/E Ratio Latest EPS DGR 3 years
45.51 0.41 3.62%
Dividend Growth


Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company operates through two worldwide business segments: BD Medical and BD Life Sciences. The BD Medical segment produces medical devices that are used in healthcare settings. This segment product includes needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes. The BD Life Sciences segment produces products for the safe collection and transport of diagnostic specimens, as well as instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The segment also produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. The principal products and services in the Life Sciences segment include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing and tuberculosis culturing systems; molecular testing systems for infectious diseases and women’s health; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; plated media; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunology and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. Becton, Dickinson & Co. was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.


Sector: Industry:
Health Technology Medical Specialties
Dividend Aristocrat

Environment, Social and Governance (ESG) Ratings

Total ESG Score

34 – 65 percentile


5 – 5 percentile


20 – 5 percentile


14 – 5 percentile

Controversy level



see MSCI ESG rating explained


Dividend aristocrats in the same sector are:
– Cardinal Health Inc. (CAH)
– AbbVie Inc. (ABBV)
– Abbott Laboratories (ABT)
– Medtronic plc (MDT)
– Johnson & Johnson (JNJ)
– West Pharmaceutical Services, Inc (WST)

Dividend Safety Metrics

Latest EPS 0.41
Annual Payout 0.00
Payout Ratio 0.00%
Dividend growth 47 Years
Dividend Score 71
Dividend Coverage Ratio 0.00
Altman-Z score 2.08 Grey Zone


Estimated Future Total Return Metrics

Total return last 5Y 8.90%
Dividend growth 5Y 4.39%
Current dividend yield 0.00%
Average dividend yield last 5Y 1.29%
Estimated EPS growth next 5Y 11.70%
Extra return due to over/under valuation -100.00%
Estimated future return 5Y (CAGR) -87.10%


Becton Dickinson (BDX) Valuation

Becton Dickinson current dividend yield of 0.00% is -100% below its 5-year average. The 5-year average dividend yield is 1.29% (see red-line in chart). This indicates the stock looks overvalued today.

Becton Dickinson (BDX) Performance

The chart below displays the total price return(%) of Becton Dickinson for different periods:


Becton Dickinson (BDX) Total Return

The chart below displays the (CAGR) total return (%) including all dividends paid of Becton Dickinson for different periods:


Dividend Scorecard

Dividend Yield (TTM) Annual Payout Payout Ratio Dividend growth
0.00 0.00 0.00% 47 Years


Dividend Growth Summary

3 Year Growth Rate (CAGR) 3.62%
5 Year Growth Rate (CAGR) 4.39%
10 Year Growth Rate (CAGR) 7.18%

Dividend Growth Rates History

Year Payout Amount Annual Payout Growth (YoY)
2022 0.870 -74.1%
2021 3.360 5.0%
2020 3.200 3.2%
2019 3.100 2.6%
2018 3.020 2.7%
2017 2.940 8.5%
2016 2.710 10.2%
2015 2.460 10.1%
2014 2.235 10.1%
2013 2.030 10.0%
2012 1.845 9.8%
2011 1.680 10.5%
2010 1.520 11.8%
2009 1.360 14.8%
2008 1.185 16.2%

Becton Dickinson (BDX) Dividend Payment History